GcMAF (Gc protein-derived macrophage activating factor) is a naturally occurring protein in the human body that plays a crucial role in the immune system. It activates macrophages, which are immune cells responsible for fighting infections and destroying cancer cells1. Here are some positive effects of GcMAF in cases of stomach cancer:

1. Immune System Activation: GcMAF activates macrophages, enhancing the body’s immune response against cancer cells.
2. Tumour Reduction: Studies have shown that GcMAF can reduce tumour volume by stimulating the immune system to attack cancer cells.
3. Nagalase Reduction: Cancer cells produce an enzyme called nagalase, which inhibits the production of GcMAF. GcMAF therapy can reduce nagalase levels, restoring the immune system’s ability to fight cancer2.
4. Improved Clinical Outcomes: Patients receiving GcMAF therapy have shown improved clinical conditions and reduced tumour progression.
5. Minimal Side Effects: GcMAF therapy is generally well-tolerated, with minimal side effects reported.
6. Enhanced Quality of Life: By reducing tumour size and improving immune function, GcMAF can enhance the overall quality of life for stomach cancer patients.
7. Potential for Long-Term Remission: Some studies have reported long-term remission in patients treated with GcMAF, indicating its potential as a long-term treatment option.
8. Non-Invasive Treatment: GcMAF therapy is a non-invasive treatment, making it a less stressful option for patients.
9. Complementary Therapy: GcMAF can be used in combination with other treatments, such as chemotherapy and radiation, to enhance overall effectiveness.
10. Natural Protein: As a naturally occurring protein, GcMAF is a more natural and potentially safer alternative to synthetic drugs.

As a precautionary measure those suffering from Ischaemia of the heart should avoid taking GcMAF in spray and injectable form.

Author of positive effects of GcMaf in cases of stomach cancer Maryjayne Aria